1 21 4

Shareholder Tools

Home Investor Relations Press Releases

Press Releases

All Releases
View Summary MacroGenics Announces Presentation of Pre-clinical Data on new DART(r) Candidate MGD011 at 56th Annual Meeting of the American Society of Hematology
Dec 6, 2014
PDF 14.6 KB Add to Briefcase
View Summary MacroGenics to Present at the Oppenheimer 25th Annual Healthcare Conference
Dec 3, 2014
PDF 12.3 KB Add to Briefcase
View Summary MacroGenics to Present at the Stifel 2014 Healthcare Conference
Nov 12, 2014
PDF 12.5 KB Add to Briefcase
View Summary MacroGenics Provides Update on Corporate Progress and Third Quarter 2014 Financial Results
Nov 11, 2014
PDF 24.5 KB Add to Briefcase
View Summary MacroGenics Announces Pre-clinical Data to be Presented at ASH 2014 Annual Meeting
Nov 6, 2014
PDF 13.8 KB Add to Briefcase
View Summary MacroGenics to Present Pre-Clinical Data on MGD006 at 26th EORTC-NCI-AACR Symposium
Oct 30, 2014
PDF 14.5 KB Add to Briefcase
View Summary MacroGenics Announces Date of Third Quarter 2014 Financial Results Conference Call
Oct 28, 2014
PDF 10.4 KB Add to Briefcase
View Summary MacroGenics and Takeda Enter Second Strategic Alliance to Develop Multiple Additional DART Therapeutics
Sep 29, 2014
PDF 17.2 KB Add to Briefcase
View Summary MacroGenics to Present at the Wedbush 2014 Life Sciences Management Access Conference
Aug 6, 2014
PDF 11.8 KB Add to Briefcase
View Summary MacroGenics Provides Update on Corporate Progress and Second Quarter 2014 Financial Results
Aug 5, 2014
PDF 22.8 KB Add to Briefcase
View Summary MacroGenics Announces Date of Second Quarter 2014 Financial Results Conference Call
Jul 29, 2014
PDF 10.3 KB Add to Briefcase
View Summary MacroGenics' DART Candidate IND for Colorectal Cancer, MGD007, Cleared to Start Enrolling Patients
Jul 24, 2014
PDF 13.3 KB Add to Briefcase
View Summary MacroGenics Initiates Phase 1 Study of MGD006 for the Treatment of Acute Myeloid Leukemia
Jun 19, 2014
PDF 14.2 KB Add to Briefcase
View Summary MacroGenics and Takeda Enter Strategic Alliance to Develop DART for Treatment of Autoimmune Disorders
May 27, 2014
PDF 53.6 KB Add to Briefcase
View Summary MacroGenics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
May 7, 2014
PDF 12.0 KB Add to Briefcase
View Summary MacroGenics Provides Update on Corporate Progress and First Quarter 2014 Financial Results
May 6, 2014
PDF 22.3 KB Add to Briefcase
View Summary MacroGenics Presents Pre-Clinical Data on Inhibition of Autoimmune Diseases With DART Candidate MGD010 at IMMUNOLOGY 2014
May 5, 2014
PDF 13.7 KB Add to Briefcase
View Summary MacroGenics Appoints Atul Saran as Senior Vice President and General Counsel
Apr 30, 2014
PDF 105.6 KB Add to Briefcase
View Summary MacroGenics Announces Date of First Quarter 2014 Financial Results Conference Call
Apr 29, 2014
PDF 10.5 KB Add to Briefcase
View Summary MacroGenics to Present Pre-Clinical Data on Novel DART Candidate MGD010 for Autoimmune Disorders at IMMUNOLOGY 2014
Apr 28, 2014
PDF 12.1 KB Add to Briefcase
Showing 1-20 of 85 Page: 1 2 3 4 5  Next 20
Add to Briefcase = add release to Briefcase